These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 23994419)

  • 101. How does successful bridging with ventricular assist device affect cardiac transplantation outcome?
    Urban M; Pirk J; Dorazilova Z; Netuka I
    Interact Cardiovasc Thorac Surg; 2011 Oct; 13(4):405-9. PubMed ID: 21788304
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Stroke while on long-term left ventricular assist device support: incidence, outcome, and predictors.
    Morgan JA; Brewer RJ; Nemeh HW; Gerlach B; Lanfear DE; Williams CT; Paone G
    ASAIO J; 2014; 60(3):284-9. PubMed ID: 24625532
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Bridge to transplant experience: factors influencing survival to and after cardiac transplant.
    Smedira NG; Hoercher KJ; Yoon DY; Rajeswaran J; Klingman L; Starling RC; Blackstone EH
    J Thorac Cardiovasc Surg; 2010 May; 139(5):1295-305, 1305.e1-4. PubMed ID: 20412961
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Periportal fibrosis without cirrhosis does not affect outcomes after continuous flow ventricular assist device implantation.
    Sargent JE; Dardas TF; Smith JW; Pal JD; Cheng RK; Masri SC; Shively KR; Colyer LM; Mahr C; Mokadam NA
    J Thorac Cardiovasc Surg; 2016 Jan; 151(1):230-5. PubMed ID: 26421983
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.
    Lietz K; Long JW; Kfoury AG; Slaughter MS; Silver MA; Milano CA; Rogers JG; Naka Y; Mancini D; Miller LW
    Circulation; 2007 Jul; 116(5):497-505. PubMed ID: 17638928
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Clinical Outcomes of Patients With the HeartMate II Left Ventricular Assist Device: A Single-center Experience From Japan.
    Seguchi O; Kuroda K; Kumai Y; Nakajima S; Yanase M; Wada K; Matsumoto Y; Fukushima S; Fujita T; Kobayashi J; Fukushima N
    Transplant Proc; 2018 Nov; 50(9):2726-2732. PubMed ID: 30401385
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Right heart dysfunction after left ventricular assist device implantation: a comparison of the pulsatile HeartMate I and axial-flow HeartMate II devices.
    Patel ND; Weiss ES; Schaffer J; Ullrich SL; Rivard DC; Shah AS; Russell SD; Conte JV
    Ann Thorac Surg; 2008 Sep; 86(3):832-40; discussion 832-40. PubMed ID: 18721570
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Association of device surface and biomaterials with immunologic sensitization after mechanical support.
    George I; Colley P; Russo MJ; Martens TP; Burke E; Oz MC; Deng MC; Mancini DM; Naka Y
    J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1372-9. PubMed ID: 18544389
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Use of sealed grafts in the HeartMate II left ventricular assist device inflow and outflow conduits.
    Gregoric ID; Radovancevic R; Patel M; Fenik Y; Cohn WE; Frazier OH
    ASAIO J; 2014; 60(3):300-3. PubMed ID: 24618753
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Lessons learned from experience with over 100 consecutive HeartMate II left ventricular assist devices.
    John R; Kamdar F; Eckman P; Colvin-Adams M; Boyle A; Shumway S; Joyce L; Liao K
    Ann Thorac Surg; 2011 Nov; 92(5):1593-9; discussion 1599-600. PubMed ID: 22051256
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Improved durability of the HeartMate XVE left ventricular assist device provides safe mechanical support up to 1 year but is associated with high risk of device failure in the second year.
    Martin J; Friesewinkel O; Benk C; Sorg S; Schultz S; Beyersdorf F
    J Heart Lung Transplant; 2006 Apr; 25(4):384-90. PubMed ID: 16563965
    [TBL] [Abstract][Full Text] [Related]  

  • 112. PREVENtion of HeartMate II Pump Thrombosis Through Clinical Management: The PREVENT multi-center study.
    Maltais S; Kilic A; Nathan S; Keebler M; Emani S; Ransom J; Katz JN; Sheridan B; Brieke A; Egnaczyk G; Entwistle JW; Adamson R; Stulak J; Uriel N; O'Connell JB; Farrar DJ; Sundareswaran KS; Gregoric I;
    J Heart Lung Transplant; 2017 Jan; 36(1):1-12. PubMed ID: 27865732
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Late-onset driveline infections: the Achilles' heel of prolonged left ventricular assist device support.
    Zierer A; Melby SJ; Voeller RK; Guthrie TJ; Ewald GA; Shelton K; Pasque MK; Moon MR; Damiano RJ; Moazami N
    Ann Thorac Surg; 2007 Aug; 84(2):515-20. PubMed ID: 17643627
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Severe upper gastrointestinal bleeding in Heartmate II induced by acquired von Willebrand deficiency: anticoagulation management.
    Sponga S; Nalli C; Casonato A; Charbonneau E
    Ann Thorac Surg; 2012 Aug; 94(2):e41-3. PubMed ID: 22579885
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Management options to treat gastrointestinal bleeding in patients supported on rotary left ventricular assist devices: a single-center experience.
    Hayes HM; Dembo LG; Larbalestier R; O'Driscoll G
    Artif Organs; 2010 Sep; 34(9):703-6. PubMed ID: 20883388
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Evaluation of low-intensity anti-coagulation with a fully magnetically levitated centrifugal-flow circulatory pump-the MAGENTUM 1 study.
    Netuka I; Ivák P; Tučanová Z; Gregor S; Szárszoi O; Sood P; Crandall D; Rimsans J; Connors JM; Mehra MR
    J Heart Lung Transplant; 2018 May; 37(5):579-586. PubMed ID: 29655662
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Bridging to transplant with the HeartMate left ventricular assist device: The Columbia Presbyterian 12-year experience.
    Morgan JA; John R; Rao V; Weinberg AD; Lee BJ; Mazzeo PA; Flannery MR; Chen JM; Oz MC; Naka Y
    J Thorac Cardiovasc Surg; 2004 May; 127(5):1309-16. PubMed ID: 15115987
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Implantable left ventricular assist device. Approaching an alternative for end-stage heart failure. Implantable LVAD Study Group.
    McCarthy PM; James KB; Savage RM; Vargo R; Kendall K; Harasaki H; Hobbs RE; Pashkow FJ
    Circulation; 1994 Nov; 90(5 Pt 2):II83-6. PubMed ID: 7955290
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Continuous-Flow Left Ventricular Assist Device-Related Gastrointestinal Bleeding.
    Kim JH; Brophy DF; Shah KB
    Cardiol Clin; 2018 Nov; 36(4):519-529. PubMed ID: 30297069
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Healthcare Resource Use and Cost Implications in the MOMENTUM 3 Long-Term Outcome Study.
    Mehra MR; Salerno C; Cleveland JC; Pinney S; Yuzefpolskaya M; Milano CA; Itoh A; Goldstein DJ; Uriel N; Gulati S; Pagani FD; John R; Adamson R; Bogaev R; Thohan V; Chuang J; Sood P; Goates S; Silvestry SC
    Circulation; 2018 Oct; 138(18):1923-1934. PubMed ID: 29807933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.